The market is dominated by domestic suppliers, as imports account for 10.0% of total market size in 2022. B2B drives market demand, with B2B spending representing 82.8% of total demand in 2022. India has the fourth largest market size for pharmaceuticals regionally, with demand reaching USD22.9 billion in 2022. Aurobindo Pharma Ltd is the largest company in India, generating 4.5% of the industry’s total production value in 2022. The industry is fragmented, with the top five companies generating 20.7% of total production value in 2022. The total number of companies decreases in 2022, to 331,401 units. The costs of the industry increase by 4.4% in 2022, largely driven by rising B2B costs. The industry’s profitability decreases and stands at 17.0% of production value in 2022, the 10th highest regionally. The industry’s exports share increases in 2022 to 50.2% of total production output. With production value of USD38.3 billion, India accounts for 5.1% of the Asia Pacific total in 2022.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in India: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in India: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!